Kiniksa Pharmaceuticals Ownership & Insider Activity

Kiniksa Pharmaceuticals International PLC

KNSANASDAQ

$72.98

-3.75-4.89%

마지막 업데이트: Oct 26, 4:22 PM

실적: Q3 2026 실적 발표가 오늘 개장 전 있습니다.

컨퍼런스 콜: 오늘 8:30 오전에 컨퍼런스 콜이 예정되어 있습니다.

Kiniksa Pharmaceuticals Ownership & Insider Activity - Benzinga

Kiniksa Pharmaceuticals (KNSA) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.0% of shares outstanding. Institutional investors hold 34.9%.

Shares Outstanding

78.024M

Shares Float

39.984M

Insider Shares Owned

753.993K

Insider % Owned

1.0%

Institutional Shares Held

27.191M

Institutional % Held

34.9%

Ownership Breakdown

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
Jul 29, 2026	Bradley Cole	—	SELL	8.173K	$81.43	$299K
Jul 15, 2026	Michael Megna	CHIEF ACCOUNTING OFFICER	SELL-OPTIONS	1.644K	$56.62	$799K
May 1, 2026	John Paolini	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$32.03	$2.5M
May 1, 2026	Sanj Patel	CHAIRMAN & CEO	SELL-OPTIONS	—	$42.48	$1.1M
Apr 28, 2026	Sanj Patel	CHAIRMAN & CEO	SELL-OPTIONS	—	$32.71	$19.6M
Apr 28, 2026	Barry Quart	—	SELL-OPTIONS	—	$32.22	$469K